UCSF

Tagged: Enhancer Elements, Genetic

UCSF School of Pharmacy leads in NIH funding for 38th year

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

Deanna Kroetz, PhD

Professor

My research seeks to understand the contribution of genetic variation to drug toxicity, to identify genetic biomarkers that can be used to guide effective use of drugs in the treatment of cancer and HIV, and to use genetics to unravel the molecular basis of drug-induced toxicity.

Nadav Ahituv, PhD

Professor

My research focuses on understanding how nucleotide variation in gene regulatory elements can lead to human disease and other phenotypes.